Breaking Down Kusuri No Aoki Holdings Co., Ltd. Financial Health: Key Insights for Investors

Peeling back the numbers on Kusuri No Aoki Holdings Co., Ltd. (3549.T) reveals a fast-growing retailer whose fiscal year to May 20, 2025, posted net sales of ¥501.47 billion (up 14.8%) and an operating profit of ¥26.60 billion (up 43.3%), even as first-quarter FY2026 results showed slight quarter-on-quarter profit softness; the balance sheet strengthened to a capital adequacy ratio of 41.4% and net assets per share of ¥1,441.69, while cash and equivalents stood at ¥47.73 billion and operating cash flow was ¥22.17 billion for the year-yet governance risk looms with activist Oasis Management seeking approximately ¥7.2 billion in damages over 2020 stock option allegations; add a market capitalization of ¥357.66 billion, a trailing EPS of ¥170.93 and a P/E of 21.78 (forward P/E 20.42) and you have a company balancing strong sales momentum (16.1% year-on-year in recent quarters and dramatic month-on-month store upticks) with buybacks (1,231,700 treasury shares for ¥4.89 billion in July 2025 and up to 6 million shares planned by June 2026) and mixed near-term profitability signals that merit a closer read.

Kusuri No Aoki Holdings Co., Ltd. (3549.T) - Revenue Analysis

• Fiscal year ending May 20, 2025: net sales ¥501.47 billion (+14.8% YoY).
• Q1 FY ending May 2026 (three months to Aug 20, 2025): net sales ¥139.70 billion (+16.1% YoY).
• Three months ending Aug 20, 2025: net sales growth +16.1% YoY (consistency with Q1 figure).
• June 2025: all stores sales +16.1% YoY.
• October 2025: all stores sales +114.1% YoY.
• January 2025: all stores sales +119.0% YoY.

• Drivers: same-store sales gains, promotional campaigns, store network expansion and product mix improvements.
• Seasonality: January and October show outsized YoY jumps, indicating calendar/marketing effects or low comparables in prior year.
• Momentum: Q1 FY2026 growth (16.1%) tracking above FY2025 full-year growth (14.8%), suggesting accelerating top-line trajectory.

Kusuri No Aoki Holdings Co., Ltd. (3549.T) - Profitability Metrics

Key profitability results for the fiscal year ending May 20, 2025 and the first quarter of the fiscal year ending May 2026, with comparable prior-period figures and year-on-year changes.

• Operating profit (FY ending May 20, 2025): ¥26.60 billion (+43.3% YoY; prior: ¥18.57 billion)
• Ordinary profit (FY ending May 20, 2025): ¥27.51 billion (+36.9% YoY; prior: ¥20.10 billion)
• Profit attributable to owners of the parent (FY ending May 20, 2025): ¥17.79 billion (+44.5% YoY; prior: ¥12.31 billion)
• Q1 (FY ending May 2026) - Operating profit: ¥7.26 billion (-1.0% YoY; prior Q1: ¥7.33 billion)
• Q1 (FY ending May 2026) - Ordinary profit: ¥7.28 billion (-1.6% YoY; prior Q1: ¥7.40 billion)
• Q1 (FY ending May 2026) - Profit attributable to owners of the parent: ¥5.03 billion (-4.1% YoY; prior Q1: ¥5.25 billion)

• Strong full-year profitability growth in FY2025 driven by meaningful expansion in operating and ordinary profit
• Early FY2026 trends show slight contraction in quarterly profitability versus year-ago quarter, warranting monitoring of margin and cost dynamics
• For background on corporate strategy and how results tie to business model, see: Kusuri No Aoki Holdings Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Kusuri No Aoki Holdings Co., Ltd. (3549.T) - Debt vs. Equity Structure

• The capital adequacy ratio rising to 41.4% indicates a stronger equity buffer relative to total assets versus the prior-year 36.4%.
• Net assets growth to ¥145.76 billion and net assets per share climbing to ¥1,441.69 reflect retained earnings and/or revaluation effects improving shareholder equity metrics.
• Active share repurchases (1,231,700 shares for ¥4.89 billion in July 2025) demonstrate management's preference for returning capital and reducing outstanding shares, which supports EPS and book-value-per-share metrics.
• The planned authorization to acquire up to 6 million shares by June 2026 could materially reduce float and increase per-share equity and EPS, depending on execution and funding (cash vs. debt).

• Leverage profile: with a higher capital adequacy ratio, Kusuri No Aoki's reliance on external debt appears reduced versus equity, improving solvency margins.
• Shareholder value mechanics: buybacks concentrate ownership and can boost ROE and EPS if not financed by excessive new debt.
• Liquidity and flexibility: the company's ability to spend ¥4.89 billion on buybacks and authorize further repurchases implies available liquidity or access to capital; investors should watch cash, short-term investments and debt levels on the consolidated balance sheet.

Kusuri No Aoki Holdings Co., Ltd. (3549.T) - Liquidity and Solvency

• Cash and cash equivalents: ¥47.73 billion as of May 20, 2025 (down from ¥48.97 billion as of May 20, 2024).
• Cash flows from operating activities (FY ending May 20, 2025): ¥22.17 billion.
• Cash flows from investing activities (FY ending May 20, 2025): ¥(31.08) billion.
• Cash flows from financing activities (FY ending May 20, 2025): ¥7.67 billion.
• Net change in cash during the year: ¥(1.24) billion, consistent with the year-over-year decline in cash balances.

• Liquidity stance: positive operating cash generation (¥22.17bn) supports near-term liquidity despite a year-over-year cash decline of ¥1.24bn.
• Investment-driven cash use: sizeable investing outflow (¥31.08bn) is the primary driver of the cash reduction-indicative of capex, M&A, or strategic investments that merit monitoring.
• Financing activity partially offset outflows: financing inflows of ¥7.67bn helped limit the decline in cash reserves.
• Balance-context suggestion: with cash of ¥47.73bn, assess short-term obligations and available committed credit to evaluate solvency under stress scenarios.

Kusuri No Aoki Holdings Co., Ltd. (3549.T) - Valuation Analysis

Key valuation metrics for Kusuri No Aoki Holdings Co., Ltd. (3549.T) as of December 12, 2025 provide a snapshot of market pricing relative to earnings and shareholder returns. These figures are essential for investors comparing relative value within the Japanese retail/pharmaceutical sector and against historical ranges.

• At a market cap of ¥357.66 billion, Kusuri No Aoki is positioned as a mid-cap player within the Japanese drugstore/retail segment.
• A trailing P/E of 21.78 implies the market is paying roughly ¥22 for every ¥1 of past-year earnings; the forward P/E of 20.42 reflects modest expected earnings growth priced in by investors.
• EPS (TTM) of ¥170.93 provides the baseline used to derive the trailing P/E; incremental EPS changes will materially affect valuation multiples.
• The dividend per share of ¥16.00 and a 0.43% yield indicate a conservative cash return policy relative to typical dividend yields in other sectors.

Relative-value considerations and sensitivity:

• P/E multiple sensitivity: a 10% change in projected EPS would move the forward P/E in the same direction, with corresponding impacts on implied share fair value.
• Dividend timing: ex-dividend date (Nov 19, 2025) is relevant for income-focused investors assessing near-term eligibility for the ¥16.00 payout.
• Comparative benchmark: compare the 20-22x range here to peers and historical averages to assess whether valuation reflects growth expectations or market premium/discount.

For further context on shareholder composition and buying trends that can drive valuation gaps, see: Exploring Kusuri No Aoki Holdings Co., Ltd. Investor Profile: Who's Buying and Why?

Kusuri No Aoki Holdings Co., Ltd. (3549.T) - Risk Factors

• July 2024 lawsuit filed by activist investor Oasis Management against the president and vice president alleging governance failures.
• Central allegation: stock options issued in 2020 were granted at significantly discounted rates, purportedly disadvantaging minority shareholders.
• Oasis Management seeks approximately ¥7.2 billion in damages and urges shareholders to oppose re-election of the implicated executives.
• The company has declined to comment on the litigation.

• Governance risk: executive-level legal exposure raises questions about board oversight, internal controls, and potential succession or reputational impacts.
• Financial risk: a reported/anticipated 17.5% decline in ordinary profit for the fiscal year ending May 2026 suggests margin pressure or operational headwinds that could compound investor concerns amid governance turmoil.
• Shareholder activism risk: Oasis's public campaign and demand to block executive re-election could spur contested AGMs, proxy battles, or further litigation expenses.
• Valuation and liquidity risk: material litigation (¥7.2 billion sought) and profit contraction may affect market valuation, credit conditions, or access to capital if uncertainties persist.

• Near-term monitoring checklist for investors:
  • Board response and any independent investigation outcomes.
  • Company disclosures regarding the disputed 2020 stock-option grants and any remediation or reserve provisions.
  • Quarterly operating performance vs. guidance to assess whether the 17.5% ordinary profit decline is a one-off or structural.
  • Progress of Oasis Management's demands, shareholder voting items, and potential settlements or judgments.

Kusuri No Aoki Holdings Co., Ltd. (3549.T) - Growth Opportunities

• Top-line momentum: The 16.1% year-over-year jump signals demand recovery and/or expansion in store sales and pharmacy services.
• Margin leverage potential: If cost control and SG&A efficiencies continue, operating leverage could enhance operating income beyond sales growth.
• Store footprint and omnichannel expansion: Continued openings, renovations, and e-commerce/pharmacy integration can sustain comparable-store growth.
• Demographic tailwinds: Aging population and rising chronic-care needs in Japan support long-term pharmacy demand.

• Investment implications: A sustained 16.1% quarterly sales uptick, if replicated across future quarters, could materially raise annual revenue guidance and investor expectations.
• Risks to monitor: reimbursement changes, margin compression from price competition, and execution risk on store/e-commerce rollout.
• Near-term catalysts: quarterly same-store sales reports, new-store pipeline announcements, and updates to pharmacy service expansions.